CompletedPhase 1NCT01634750
Phase I Clinical Trial of ManNAc in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy (HIBM)
Studying GNE myopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Human Genome Research Institute (NHGRI)
- Principal Investigator
- Nuria Carrillo-Carrasco, M.D., M.DNational Human Genome Research Institute (NHGRI)
- Intervention
- ManNAc(drug)
- Enrollment
- 26 enrolled
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2012 – 2013
Study locations (1)
- National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Collaborators
National Center for Advancing Translational Sciences (NCATS) · Therapeutics for Rare and Neglected Diseases (TRND)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01634750 on ClinicalTrials.govOther trials for GNE myopathy
Additional recruiting or active studies for the same condition.